Pituitary Adenylate Cyclase-Activating Peptide is a Potent Modulator of Human Colonic Motility

H. Schwörer Dept. of Medicine, Division of Gastroenterology and Endocrinology, Dept. of Surgery, University of Göttingen, Göttingen, Germany

A. Clemens Dept. of Medicine, Division of Gastroenterology and Endocrinology, Dept. of Surgery, University of Göttingen, Göttingen, Germany

S. Katsoulis Dept. of Medicine, Division of Gastroenterology and Endocrinology, Dept. of Surgery, University of Göttingen, Göttingen, Germany

H. Köhler Dept. of Medicine, Division of Gastroenterology and Endocrinology, Dept. of Surgery, University of Göttingen, Göttingen, Germany

W. Creutzfeldt Dept. of Medicine, Division of Gastroenterology and Endocrinology, Dept. of Surgery, University of Göttingen, Göttingen, Germany

W. E. Schmidt Dept. of Medicine, Division of Gastroenterology and Endocrinology, Dept. of Surgery, University of Göttingen, Göttingen, Germany

Abstract

Pituitary adenylate cyclase-activating peptide (PACAP) represents a novel brain-gut peptide with high sequence homology to vasoactive intestinal polypeptide (VIP). Since PACAP has been identified in the human gut, the effect of the two molecular forms PACAP-(l-38) and PACAP-(l-27), the hybrid PACAP-(l-23)VIP-(24-28), and VIP on the contractility of the longitudinal muscle of human sigmoid colon was tested in vitro. All peptides inhibited the spontaneous phasic contractions and relaxed concentration-dependently carbachol-precontracted preparations. The effects of the peptides remained unaffected by tetrodotoxin, by inhibition of phosphodiesterase activity, and by inhibition of nitric oxide synthesis. Apamin reduced only the effects of the PACAP peptides, whereas tetraethylammonium blocked only the effect of VIP. In conclusion, PACAP peptides and VIP mediate their relaxant effects via activation of specific PACAP and VIP receptors coupled to different potassium channels.

Key Words:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Pituitary Adenylate Cyclase-Activating Peptide is a Potent Modulator of Human Colonic Motility

Information for

Open access

Opportunities

Help and information

Pituitary Adenylate Cyclase-Activating Peptide is a Potent Modulator of Human Colonic Motility

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature